Company / Named in our posts
F-star.
Follow F-starF-star is a clinical-stage biopharmaceutical company pioneering bispecifics in immunotherapy, with a focus on improving lives for people with cancer.[1]
01Deal
Deals on Carrywatch
Every deal that names F-star, and its role in each.
invoX / F-star
invoX Pharma Limited completes F-star Therapeutics acquisition
See deal detailsDeal Web
F-star and 0 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01INVOX PHARMA COMPLETES ACQUISITION OF F-STAR THERAPEUTICS, INC.
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming F-star:
- P01